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Article
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Mucosal-associated invariant T (MAIT) cells express a semiinvariant  T cell receptor
(TCR) that binds MHC class I–like molecule (MR1). However, the molecular basis for MAIT
TCR recognition by MR1 is unknown. In this study, we present the crystal structure of a
human V7.2J33-V2 MAIT TCR. Mutagenesis revealed highly conserved requirements
for the MAIT TCR–MR1 interaction across different human MAIT TCRs stimulated by
distinct microbial sources. Individual residues within the MAIT TCR  chain were dispensable for the interaction with MR1, whereas the invariant MAIT TCR  chain controlled
specificity through a small number of residues, which are conserved across species and
located within the V-J regions. Mutagenesis of MR1 showed that only two residues,
which were centrally positioned and on opposing sides of the antigen-binding cleft of
MR1, were essential for MAIT cell activation. The mutagenesis data are consistent with a
centrally located MAIT TCR–MR1 docking that was dominated by the  chain of the MAIT
TCR. This candidate docking mode contrasts with that of the NKT TCR–CD1d-antigen
interaction, in which both the  and  chain of the NKT TCR is required for ligation above
the F-pocket of CD1d.
CORRESPONDENCE
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Abbreviations used: CDR,
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invariant T; MFI, mean fluores
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peptides complexed to
MHC; V, variable.

Antigen (Ag)-specific immunity is orchestrated
by T cells that determine the specificity of
immune responses via their clonally distributed
 TCRs. A wide array of Ags is presented to
TCRs, and to counteract this diversity, the host
possesses a vast T cell repertoire. TCR diversity is generated via gene rearrangement within
the variable (V) domains of the TCR; namely,
the V and junction (J) gene segments define the
V chain, whereas the V chain is composed
of rearranged V, D (diversity), and J gene segments, in addition to non–nucleotide-encoded
diversity (N) at these gene segment boundaries.
This diversity is manifested in the complementarity determining regions (CDR) of the TCR,
R. Reantragoon, L. Kjer-Nielsen, and O. Patel contributed
equally to this paper.
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providing key sites that interact with the Agpresenting molecule (Clements et al., 2006).
Despite this TCR diversity and its importance
in immunity, there are numerous examples of
TCR bias in protective immunity and autoimmunity in which restricted V gene usage
and/or sequence conservation within CDR3
loops defines the immune response to specific
Ags (Turner et al., 2006; Godfrey et al., 2008;
Gras et al., 2008). Why this should occur, and
the factors that shape biased TCR usage, remain unclear.
TCRs recognize peptides complexed to
the MHC (pMHC), and the insight gleaned
© 2012 Reantragoon et al. This article is distributed under the terms of an
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first
six months after the publication date (see http://www.rupress.org/terms).
After six months it is available under a Creative Commons License (Attribution–
Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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detected in human blood, the gastrointestinal mucosa, and
mesenteric lymph nodes. Furthermore, MAIT cells, like NKT
cells, rapidly produce a broad range of cytokines upon activation (Kawachi et al., 2006; Martin et al., 2009). There are
further parallels between MR1-restricted MAIT cells and
CD1d-restricted NKT cells in that, like NKT cells, MAIT
cells express a semiinvariant TCR comprised of an invariant TCR  chain (V19J33 in mice, or the homologous
V7.2J33 in humans) in combination with TCR-V6 or
V8 in mice, TCR-V2 or V13 in humans (Tilloy et al.,
1999). The semiinvariant and evolutionarily conserved nature
of the MAIT TCR suggests that MAIT cells may potentially
be specific for an important, albeit limited and atypical, class
of Ags presented by the MR1 molecule. Nevertheless,
despite the limited TCR repertoire of MAIT cells, they respond
to a surprisingly broad range of microorganisms, including
diverse strains of bacteria and yeast, suggesting the existence
of a conserved Ag (or family of Ags), which is common to
these cellular organisms, presented to MAIT cells in an MR1dependent manner (Gold et al., 2010; Le Bourhis et al., 2010).
Indeed, endogenous cell surface expression levels of MR1
are very low, suggesting that a bacterial Ag is required to
stabilize MR1 and/or increase its MR1 presentation (Chua
et al., 2011). Alternatively, it is possible that bacterial infection may indirectly result in MAIT cell activation through
activation of Toll-like receptors or other innate pathways, as
occurs for NKT cells (Brigl et al., 2011). However, this seems
unlikely for MAIT cells, as previous studies indicate that
their activation can occur independently of My88D, TRIF,
Nod1,-2, N1rp3, Asc, Ips TLR2, and TLR4 (Gold et al.,
2010; Le Bourhis et al., 2010). Furthermore, MAIT cells can
be activated by fixed APCs cultured in the presence of bacteria in an MR1-dependent manner (Le Bourhis et al., 2010).
Hence, it is a simpler proposition that MAIT cell activation
results from TCR recognition of MR1 complexed with a
bacterial Ag, although the nature of a candidate bacterial Ag
has yet to be identified.
Because MAIT cells are largely defined by their unique,
semiinvariant TCR, their Ag-restricting element (MR1),
and, potentially, an unusual Ag specificity (Huang et al., 2008,
2009), a critical step in understanding the biology of these
cells will be to understand their TCR-specificity.
RESULTS
MAIT TCR structure
In humans, the MAIT TCR comprises the TRAV1-2  chain
(V7.2-J33) and is generally assembled with either the TRBV6
(V13) or TRBV20 (V2)  chains, with the CDR3 loop
being hypervariable (Tilloy et al., 1999). In mouse MAIT cells,
V19-J33 assembles with either TRBV-19 (V6) or TRBV13
(V8). We expanded and cloned MAIT cells from the PBMCs
of a healthy donor and isolated the TCR  and  chain cDNAs
for further investigation. Three clones were selected, each
expressing the V7.2-J33 assembled with either a V13.3
(clone BV6-1), V13.5 (clone BV6-4), or V2  chain (clone
BV20). TRBV6-1 (V13.3) and TRBV20 (V2) sequences
MAIT TCR–MR1 recognition | Reantragoon et al.
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from structures of TCR–pMHC complexes has been extremely informative in understanding how the TCR simultaneously, and specifically, focuses with host MHC and fragments
of foreign peptide Ag (Rudolph et al., 2006; Marrack et al.,
2008; Burrows et al., 2010). However, there are other Agpresenting molecules of the immune system that the TCR
specifically interacts with. For example, the CD1 family presents lipid-based Ags to T cells (Godfrey et al., 2008). The
most extensively studied group of T cells that interact with
lipid-based Ags are the natural killer T (NKT) cells, which
express an NKT TCR that specifically recognizes CD1d-Ag
in mice and humans (Bendelac et al., 2007; Godfrey et al.,
2010a). Similar to some MHC-restricted responses, NKT
cells use a limited range of TCR genes, such that human
NKT cells typically express an invariant V24-J18 rearranged TCR  chain and most express a V11 TCR  chain
(Godfrey et al., 2010a). The most widely studied glycolipid Ag for activating NKT cells is a synthetic -glycolipid,
-galactosylceramide. The structures of human and mouse
NKT TCRs in complex with CD1d--galactosylceramide
and other lipid Ags have recently been determined (Godfrey
and Rossjohn, 2011). These NKT TCR–CD1d-Ag complexes demonstrate a conserved docking strategy that differs
from all known TCR-pMHC interactions, whereupon the
NKT TCR adopted a tilted and parallel docking mode in relation to the CD1d Ag-binding cleft (Godfrey et al., 2008).
The invariant NKT TCR  chain dominated this inter
action, with the CDR1 loop predominantly interacting with
the lipid Ag, whereas the CDR3 loop played a central role,
contacting CD1d and the lipid Ag. The roles of the human
V11 and the homologous mouse V8.2 chain were essentially restricted to the CDR2 loop that interacted with
CD1d (Godfrey et al., 2010a; Joyce et al., 2011). Nevertheless, the CDR3 loop can play an important role in determining CD1d autoreactivity (Matulis et al., 2010; Mallevaey
et al., 2011). Thus, the structural studies have been very informative in understanding how a TCR can recognize a lipid-laden
Ag-presenting molecule, but it remains unclear how TCRs can
interact with other specialized Ag-presenting molecules of
the immune system.
Mucosal-associated invariant T (MAIT) cells are a subpopulation of T cells that are restricted by the monomorphic
MHC class 1–like molecule (MR1; Treiner et al., 2003;
Gapin, 2009; Le Bourhis et al., 2011). The role of MAIT
cells in immunity is emerging and is supported by their conservation across species such as humans, cattle, and mice, as
well as recent data implying protective function in autoimmunity and certain infections (Gold et al., 2010; Le Bourhis
et al., 2010; Le Bourhis et al., 2011; Miyazaki et al., 2011;
Chiba et al., 2012). In some regards, MAIT cells are reminiscent of CD1d-restricted NKT cells, although in humans,
MAIT cells are much more abundant, comprising 1–10% of
peripheral blood T cells when compared with their NKT cell
counterparts (typically <0.1%), and MAIT cells can constitute up to 50% of liver T cells (Godfrey et al., 2010b;
Dusseaux et al., 2011). Indeed, MAIT cells are readily
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Table 1.

Data collection and refinement statistics
MAIT TCR

Data collection
Temperature (K)
Resolution limits (Å)
Space group
Cell dimensions (Å)
Total no. observations
No. unique observations
Multiplicitya
Data completenessa
I/1a
Rp.i.ma,b (%)
Refinement statistics
Rfactorc (%)
Rfreed (%)
Nonhydrogen atoms: protein/ water
Ramachandran plot: most favored/
allowed region (%)
B-factors: average main chain/
average side chain/water (Å2)
rmsd bonds (Å)
rmsd angles (°)
aValues

100
50-1.7 (1.79-1.70)
P212121
a = 41.96; b = 64.51; c = 155.12;
 =  =  = 90.00°
351,526
45,957
7.6 (7.4)
97.1 (92.6)
13.7 (2.5)
3.5 (28.5)
19.1
23.1
3,472/271
89.1/10.9
17.3/20.4/26.7
0.014
1.500

in parentheses refer to the highest resolution bin.

bR
1/2  | I
p.i.m = hkl [1/(N  1)]
i
hkl, i <Ihkl> | / hkl <Ihkl>
cR
factor = ( | |Fo| |Fc| |) / ( |Fo|), for all data except as
d5% of data were used for the R
free calculation

JEM Vol. 209, No. 4

indicated in footnote d.

the V2 MAIT TCR (Fig. 1 B). All six CDR loops were
well-ordered in the electron density, suggesting little mobility of these CDR loops, in contrast to the flexibility of the
CDR loops typical of several MHC-restricted TCRs (Garcia
et al., 1998; Reiser et al., 2002; Godfrey et al., 2008), implying that the MAIT TCR possesses a rigid, preformed MR1binding interface.
Unless explicitly stated, comparative structural analyses
have been restricted to the semiinvariant human V24-V11
NKT TCR (NKT15; Kjer-Nielsen et al., 2006; Fig. 1 C).
The root mean square deviation for the pairwise superposition
between the V2 MAIT TCR and the V11 NKT TCR
was 0.90 Å (347 residues), highlighting that these semiinvariant TCRs adopt very similar topologies. Although the
constant domains of the V2 MAIT and V11 NKT TCR
superpose closely with each other (root mean square deviation [rmsd], 0.33 Å; 160 residues), differences in juxtaposition
between the V and V domains were observed, reflecting
differences in the interchain pairing of the NKT TCR and the
MAIT TCR. Moreover, comparative analyses revealed structural divergences within the respective V and V domains.
For example, pairwise superposition between MAIT and NKT
V domains was 0.45 Å (75 residues), whereas the pairwise
superposition between the V domains was 0.70 Å (75 residues),
showing that the V domain was more divergent than the
V domain, as expected from the markedly differing nature
of the V chains. Further, although the CDR1 loop adopts
a similar conformation to the corresponding loop in the NKT
TCR (Kjer-Nielsen et al., 2006), the remaining CDR loop
conformations are markedly different, presumably reflecting the fact that the MAIT and NKT TCRs engage MR1
and CD1d, respectively (Fig. 1 and Fig. 2).
The MAIT TCR V-V interface uses both the V7.2
and J33 gene segment of the invariant chain. The sequences
encoded by the invariant J and hypervariable D-N-J
region create the CDR3 loops that are centrally located at
the Ag-binding interface (Fig. 1 B). Namely, the residues
lining this region are mostly apolar in nature, in stark contrast to the electropositive surface of NKT TCR (Fig. 2 A).
The central binding pocket of the MAIT TCR is comprised of Met91 and Arg97, which is flanked by Tyr95
from the CDR3 loop and Phe102 from the CDR3
loop, the latter of which packs against framework residue
Tyr48 from the CDR2 loop (Fig. 2 B). The tips of the
CDR1, CDR2, and CDR3 loops are polar (Ser27,
Asn30, Asp52, Asp92, and Asn94), if not featureless
(Fig. 2 C). The residues from the germline-encoded regions
of the V chain are mostly flat and featureless, with Glu52
from the CDR2 loop, and Phe28 from the CDR1 loop
representing prominent side chains, nevertheless Phe28 lies
parallel with, and away from the Ag-binding interface (Fig. 2 D).
Thus, in marked contrast to that of the NKT TCR, which
possesses a large number of charged residues within the CDR3
loop, the J18-encoded CDR3 loop, and two tyrosine
residues encoded within the CDR2 loop (Fig. 2, E and F),
a defining feature of the MAIT TCR is the cluster of
763

Downloaded from https://rupress.org/jem/article-pdf/209/4/761/637706/jem_20112095.pdf by Washington University In St. Louis Libraries user on 14 December 2019

were derived from published sequence data (Tilloy et al.,
1999). The TRBV6-4 (V13.5) sequence was derived from
FACS single-cell sorting and RT-PCR analysis. A sequence
alignment of the CDR loops of the three MAIT TCRs is shown
(Fig. S1 and Fig. S2).
To begin to understand MAIT TCR function, the extracellular domains of the two V13 and single V2 MAIT
TCRs were expressed in Escherichia coli, refolded into a native
conformation, and purified. The functional integrity of the
refolded TCRs was assessed by gel filtration chromatography
and ELISA reactivity with the TCR-specific conformationdependent mAb 12H8 (unpublished data). Although the two
V13 MAIT TCRs failed to crystallize (not depicted), the
V2 MAIT TCR crystallized, and its structure was subsequently determined to 1.7 Å resolution (Table 1). Given the
resolution, the quality of the electron density for the V2
MAIT TCR, and in particular the Ag-binding site, was excellent (Fig. 1 A).
The overall structure of the MAIT V2 TCR resembles
that of other MHC- and CD1d-restricted  TCRs, namely
it comprises four immunoglobulin-like domains with a constant (C) and variable (V) domain in each chain, with their
respective domains packing against each other (Fig. 1 B;
Kjer-Nielsen et al., 2002; Rudolph et al., 2006). The V domain of each chain is composed of three CDRs and together
these six hypervariable loops form a ligand-binding site for

MAIT TCR recognition is more dependent on the invariant encoded  chain,
with a less obvious contribution from
the V residues.

aromatic residues within the central region of its combining site (Fig. 2 B).
The MAIT TCR V chain is highly conserved across
species (Tilloy et al., 1999), with the surface exposed residues from the CDR1 loop (Ser27, Gly28, and Asn30),
the CDR2 loop (Tyr48, Val50, Leu51, Asp52, and
Gly53), and the CDR3 loop (Asp92, Asn94, Tyr95,
and Ile98) conserved across four species (Goldfinch et al.,
2010). However, there is less conservation in the germlineencoded CDR loops of the V2 and V13 chains, with a
conserved Asn-His-Asp motif present in the CDR1 loop
of mouse V6 and V8.1 (Fig. S2). However, human V2
and V13 do not contain this motif, and there is little conservation of CDR2 loops across, or within, human and
mouse sequences apart from a Tyr/Thr-Ser motif at the
junction of this loop (Fig. S2). Accordingly, the structural
data suggests that although the MAIT TCR resembles the
overall architecture of MHC- and CD1d-restricted TCRs,
764

MAIT–MR1 recognition
It is thought that MAIT cells may be able
to potentially recognize unknown microbial Ags presented by MR1 (Gold et al.,
2010; Le Bourhis et al., 2010), although
definitive identification of a bacterially encoded Ag is lacking at present. To explore
the activation of human MAIT TCRs by
MR1, we transduced genes for MAIT
TCRs using TRBV20 (V2), TRBV6-1
(V13.3), or TRBV6-4 (V13.5)  chains
into either of the two human leukemia
T cell lines SKW3 (Hundhausen et al.,
1992; Gras et al., 2010) and Jurkat (Gillis
and Watson, 1980), thus creating clonal
cellular reagents for T cell recognition
(SKW3.TRBV20, SKW3.TRBV6-1, and
SKW3.TRBV6-4; Jurkat.BV20, Jurkat.
BV6-1, and Jurkat.BV6-4). To generate
Ag-presenting cells, HeLa cells and the
MHC-I–deficient human lymphoblastoid
cell line C1R were transduced with the gene for human
MR1. C1R cells express low levels of endogenous MR1, and
thus were also used as untransduced APCs (Fig. 3 A). T cell
activation was assayed by CD69 up-regulation that was determined by flow cytometry. Mindful that MAIT cells can be
activated by various strains of bacteria (Gold et al., 2010;
Le Bourhis et al., 2011), we first determined that SKW3 T cells
transduced with MAIT TCRs were activated by Ag-presenting
cells infected with Salmonella enterica serovar Typhimurium.
SKW3.TRBV20 MAIT cells were activated by C1R cells
(expressing endogenous MR1) only when infected with
S. typhimurium, and this activation was blocked by addition of
the MR1-specific mAb 26.5 (Huang et al., 2005) but not by
the MHC-I-specific mAb W6/32 (Parham et al., 1979; Fig. 3 B).
Similar results were obtained when SKW3.TRBV6-1 and
SKW3.TRBV6-4 cells were used as responder cells (unpublished data). Similarly, HeLa cells transduced with MR1 could
activate Jurkat.BV6-1 cells (Fig. 3 C), as well as Jurkat.BV20
MAIT TCR–MR1 recognition | Reantragoon et al.
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Figure 1. Structures of MAIT and NKT TCRs.
(A) 2Fo-Fc electron density map shown as a blue
mesh and contoured at 1 sigma for the CDR3
and CDR3 of the MAIT TCR. (B) Structure of
MAIT TCR and amino acid composition of CDR3
loops. TCR chain, cyan; TCR chain, light green;
CDR1, purple; CDR2, dark green; CDR1, teal,
CDR2, ruby; CDR3 loops, color coded according
to their genetic origin (right). (C) Structure of NKT
TCR and amino acid composition of CDR3 loops.
TCR chain, salmon; TCR chain, gray; CDR loops,
color coded as in B.

Ar ticle

and Jurkat.BV6-4 cells (not depicted). Activation of MAIT
TCR–transduced SKW3 and Jurkat cells was dependent on
the multiplicity of infection (MOI) of S. typhimurium infection, and this activation was blocked by the MR1-specific
mAb 26.5. Thus, both the SKW3 and Jurkat cell lines transduced with MAIT TCRs were activated in an MR1-restricted manner.
Specificity determinants of the MAIT-MR1 interaction
To further probe the underlying basis of the MR1-induced
MAIT TCR activation, we generated a panel of MAIT
TCR mutants based on the nonliganded V2 (TRBV20)
MAIT TCR structure. In total, 25 single-site alaninescanning mutations were made in the TRBV20 MAIT
TCR, 11 in the V chain (CDR1: Ser27, Gly28, and
Asn30; CDR2: Tyr48, Val50, Leu51, and Asp52; CDR3:
Asp92, Ser93, Asn94, Tyr95), and 14 in the V chain (CDR1:
Leu26, Phe28, Gln29, Thr31, and Thr32; CDR2: Asn51,
Glu52, Gly53, Ser54, and Lys55; CDR3: Arg97, Ser99,
JEM Vol. 209, No. 4

Gly100, and Phe102). Leu26Ala
was remote from the likely MAIT
TCR–MR1-Ag–binding site and was
selected as a negative control, whereas
all the other mutants were at surface
exposed positions within the CDR
loops. As these residues were surface
exposed, they were unlikely to affect
the conformation of the CDR loop
per se, and thus their mutation was
predicted to not indirectly impact on
MR1-induced activation. Thus, any
effect observed by these alanine mutations could be attributable to impacting directly on MR1 binding.
Constructs containing MAIT TCR alanine mutations
were transduced into SKW3 and Jurkat cells, and the cell
surface expression of MAIT TCR was closely matched as
determined by flow cytometry using staining for cell surface CD3 expression and coexpression of GFP (unpublished
data). We then tested the impact of these mutants using
C1R APCs infected with S. typhimurium (Fig. 4). We observed that mutations at six residues markedly impaired responses (Gly28, Asn30, Tyr48, Asp92, Asn94, and
Tyr95; Fig. 4 A). Surprisingly, none of the  chain mutants
showed decreased activation responses to S. typhimurium,
suggesting that no individual residue within the  chain was
essential for the MAIT TCR–MR1 recognition (Fig. 4 B).
All 25 of the mutant SKW3 cells expressing TRBV20 Alasubstitutions were activated by beads coated with anti-CD3 and
anti-CD28 mAbs indicating intact signaling capacity was retained by the mutant TCRs (unpublished data). Similar results
765
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Figure 2. Electrostatic surface and
close-up view of CDR loops. (A) Electrostatic calculations were performed using the
MAIT TCR and NKT TCR (Protein Data Bank
accession code 2EYS). Coordinate preparation
was performed using the PDB2PQR server
(v1.7; Dolinsky et al., 2007). Electrostatic calculations were subsequently performed using
the APBS plug-in in PyMOL (DeLano, 2002;
v1.1.0 and v1.2.x, respectively) with 0.15 M
concentration for the +1 and 1 ion species.
(B) Central binding pocket of the MAIT TCR.
CDR2, dark green; CDR3, yellow; CDR3,
orange. (C) Residues at the tip of CDR loops
of MAIT TCR. CDR1, purple; CDR2 and
CDR3, color coded as in B. (D) CDR1 (teal)
and CDR2 (ruby) loops of the MAIT TCR.
(E) Central binding pocket of the NKT TCR.
CDR loops, color coded as in B. (F) Tyrosines
of the CDR2 loop (ruby) of the NKT TCR.
(G) Energetically important residues at the binding interface of the MAIT TCR. TCR  chain,
cyan; TCR chain, light green; CDR1, purple;
CDR2, dark green; CDR3, yellow; CDR1,
teal, CDR2, ruby; CDR3, orange. Energetically
important residues are shown in red.

Role of the V interactions in MAIT specificity
To further examine the role of V residues in MAIT TCR
activation we examined the impact of alanine mutations in
five solvent exposed CDR1 residues (Asn28, His29, Asn30,
Ser31, and Tyr33; as well as a control residue, Asn66, of the
MAIT TRBV6-1 TCR. The structure of the SB27 TCR
(Tynan et al., 2005b) was used to determine solvent exposed residues in the CDR1 loop of the TRBV6-1  chain
from the MAIT TRBV6-1 TCR. Constructs containing
these alanine mutations were transduced into SKW3 cells
that were matched for TCR expression as described above.
Testing the impact of these mutants using wild-type C1R
APCs infected with S. typhimurium revealed that none of
the mutants individually had an adverse impact on MR1restricted activation by the mutated MAIT TCRs (Fig. 4 C).
These findings underscore the observation that no individual germline-encoded residue within the V chain is
essential in mediating MR1-restricted activation of the
MAIT TCR.
Next, given that none of the individual CDR3 mutations in TRBV20 had any apparent impact on MAIT cell activation, we created T cells expressing TCRs where the whole
CDR3 of a MAIT TCR was swapped for that of another with
non–MAIT TCR specificity. For this purpose, we selected two
unrelated T cell clones with V usage similar to MAIT clone
TRBV6-1 and clone TRBV20. The first, SB27, recognizes
HLA-B*3501 complexed to a peptide from an Epstein–Barr
virus Ag and uses a TRBV6-1  chain similar to the  chain
766

of the MAIT clone
BV6-1(Tynan et al.,
2005a,b). Second,
clone ABC recognizes HLA-B*5701
and the drug abacavir and expresses
a TRBV20  chain similar to the  chain of MAIT clone
TRBV20. The CDR3 loop of MAIT clone 6–1 was replaced with the SB27 CDR3 loop, whereas the CDR3
loop of MAIT clone TRBV20 was replaced with the CDR3
loop of clone ABC, and these hybrid TCRs were expressed with V7.2J33 in SKW3 T cells (Fig. S3). When
stimulated by C1R cells infected with S. typhimurium, neither
the SKW3 cells expressing MAIT.TRBV6-1/SB27.CDR3
nor the cells expressing MAIT.TRBV20/ABC.CDR3
were activated (Fig. 4 D). Activation by anti-CD3 and
anti-CD28 beads was identical in all transduced T cells
(unpublished data), and the parental wild-type MAIT cells were
activated normally by S. typhimurium–infected C1R cells. Accordingly, although single-residue mutants in the CDR3
of the MAIT-TRBV20 TCR had no impact on MAIT TCR
activation, swapping the full CDR3 loop of both this
MAIT-TRBV20 TCR and the MAIT-TRBV6-1 TCR completely abolished MAIT TCR activation in both of these
clones. This indicates that redundancy in the important
contacts from this loop or that the conformation of the
CDR3 loop can impact on the MAIT TCR–MR1 interaction, possibly via steric hindrance mechanisms.
Identical TCR specificity pattern independent
of bacterial stimulators
We next examined whether the specificity pattern observed
in the TRBV20 SKW3 mutants stimulated by S. typhimurium
was the same or different when the cells were stimulated by
MAIT TCR–MR1 recognition | Reantragoon et al.
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were obtained using transduced Jurkat cells as T cells responders and we observed the Jurkat cells were slightly less
sensitive than the transduced SKW3 cells (unpublished
data). Thus, the mutational data suggest a limited number of
V residues of the MAIT TCR are critical for the MR1induced activation.

Figure 3. Characterization of APC lines
and MAIT TCR-transduced T cell lines.
(A) Staining of HeLa and C1R cells with the
MR1-reactive mAb 26.5 by indirect immunofluorescence. FACS histograms compare intensity of staining with either an isotype
control antibody 8A5 (+ Isotype), or with antiMR1 antibody (+26.5). HeLa and C1R cells
transduced with MR1 were also stained with
26.5 (h.MR1 + 26.5). (B) SKW3.TRBV20 cells
were incubated with C1R cells infected with
Salmonella typhimurium, either in the absence (No Ab) or presence of either an
MR1-reactive mAb (+ 26.5) or the HLA class I–
reactive mAb W6/32 (+ Isotype). SKW3.
TRBV20 cells were subsequently stained for
CD69 cell surface expression (mean fluorescence intensity [MFI] values shown) and analyzed by flow cytometry. (C) Jurkat.TRBV6-1
cells were incubated with MR1-transduced
HeLa cells infected with S. typhimurium,
either in the absence (No Ab) or presence of
either an MR1-reactive mAb (+ 26.5) or the
HLA class I–reactive mAb W6/32 (+ Isotype).
Jurkat.TRBV6-1 cells were subsequently
stained for CD69 cell surface expression (MFI
values shown) and analyzed by flow cytometry. Experiments in A–C were performed
three times, with similar results.
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other bacteria. C1R APCs were independently infected with
either the Gram-negative bacteria Escherichia coli, Klebsiella
pneumoniae, and Pseudomonas aeruginosa or with the Grampositive bacterium Staphylococcus epidermidis, and the infected
APCs were used to stimulate the SKW3.TRBV20 mutant
T cells (Fig. 5). The pattern of T cell activation was indistinguishable from that observed when the mutants were stimulated by C1R infected with S. typhimurium, such that V
residues Gly28, Asn30, Tyr48, Asp92, Asn94, and Tyr95
markedly reduced MAIT TCR activation. Again, there was no
consistent influence of TCR  chain mutations on T cell activation by any of the bacteria, with the exception of assay
variation in T cell responses of some of the V mutants (e.g.,
S. epidermidis, Gly100Ala, and Phe102Ala). These results
suggest that the MAIT TCR acts like a pattern recognition
receptor, with a conserved MR1-binding mode, irrespective
of the source of bacterial stimulation.
JEM Vol. 209, No. 4

Conserved fine specificity by other MAIT TCRs
We next examined whether the same pattern of MAIT TCR
specificity was evident when the mutated TRAV1-2  chains
(V7.2-J33; selected  chain mutants: Ser27, Gly28, Asn30,
Tyr48, Asp92, Ser93, Asn94, and Tyr95) were paired with other
MAIT V families (Tilloy et al., 1999). Thus, we transduced
SKW3 T cells with genes encoding the mutant TRAV1-2
(V7.2/J33) TCR  chain and either the TRBV6-1 or the
TRBV6-4  chains, representing the alternate V13 family
preferentially used by some human MAIT cells. The transduced cells were stimulated by C1R APCs infected with
S. typhimurium, K. pneumoniae, P. aeruginosa, or S. epidermidis,
and activation of SKW3 cells was determined by staining and
flow cytometric analysis of surface CD69 expression (Fig. 6,
A and B). Except for activation responses in SKW3.TRBV6-4
cells with the Asn94Ala mutation being only minimally impaired, the fine specificity pattern of reactivity of the TCR 
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Figure 4. Activation of mutant SKW3.BV20 cells by S. typhimurium. 11 mutant  chain (A) and 14 mutant  chain (B) SKW3.TRBV20 cell lines
were incubated with C1R cells infected with S. typhimurium at a MOI of 100. Shaded bars show the fold increase in CD69 surface expression (fold increase in MFI) of mutant SKW3.TRBV20 cells co-incubated with C1R cells infected with S. typhimurium compared with SKW3.BV20 cells co-incubated
with uninfected C1R cells (open bars). A positive control, wild-type SKW3.TRBV20 (TRBV20.WT), and a negative control, SKW3.LC13 (LC13.WT), were included. The mutant CDR1 Leu26A cell line was included as an internal control where activation was expected to remain intact. (C) MAIT.TRBV6-1 TCRs
with six separate solvent-exposed residues of the  chain mutated to alanine were transduced into SKW3 cells and tested in the same manner as the
mutant SKW3.TRBV20 cell lines in A and B. (D) SKW3 cells transduced with MAIT TCRs containing CDR3 regions of the MAIT.TRBV6-1 TCR or the MAIT.
TRBV20 TCR exchanged with the CDR3 regions of known functional TCRs using TRBV6-1 or TRBV20, respectively, were then tested in the same manner
as the mutant SKW3.TRBV20 cell lines in A and B. The following SKW3-transduced cell lines were tested: wild-type SKW3.TRBV6-1 cells (TRBV6-1.WT);
SKW3.TRBV6-1 cells with a TCR containing the SB27 TRBV6-1 CDR3 region (TRBV6-1/SB27); wild-type SKW3.TRBV20 cells (TRBV20.WT); SKW3.TRBV20
cells with a TCR containing the ABC TRBV20 CDR3 region (TRBV20/ABC; to be described elsewhere); SKW3 cells with a TCR containing the MAIT invariant  chain paired with the LC13 TCR  chain (MAIT.LC13); and SKW3 cells with the wild-type LC13 TCR (LC13.WT). The experiments shown in A–D
were also performed at an MOI of 1 and 10 and yielded similar results (not depicted). The experiments shown in A and B and C and D were done three
times and twice, respectively, with similar results.

chain mutants was otherwise very similar to that observed
for the SKW3.TRBV20 cells, regardless of the source of the
TCR  chain or the source of bacterial stimulation, again
suggesting a passive role for the TCR  chain in direct
Ag-specificity observed in our system. Specific responses were
blocked by the anti-MR1 mAb 26.5 and were dose dependent (unpublished data). Accordingly, MR1-restricted
MAIT TCR–mediated activation is not modulated appreciably by the TCR  chain, and is determined by the invariant  chain (Fig. 2 G).
A small energetic footprint on MR1
Having established that a small number of MAIT TCR residues were essential for MR1 recognition, we next explored
whether the MAIT TCR–MR1 interaction was underpinned
by a focused energetic “hot spot” on MR1. To establish this,
we generated a homology model of human MR1 (see Materials and methods) and selected 14 residues, 6 on the 1-helix
(Asp57, Arg61, Leu65, Met72,Val75, and Arg79) and 8 on the
2-helix (Thr138, Gln141, Asn146, His148, Leu151, Asn155,
Glu158, and Arg167). The selected residues were exposed to
solvent, and thus represented potential MAIT TCR contact
points. Moreover, the residues targeted for mutagenesis included
charged, polar, and hydrophobic residues, and ran along the
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length and breadth of the Ag-binding cleft of MR1. Accordingly, the MR1 mutagenesis approach enabled us to gain a
broad perspective on the chemistry of the interaction, as well
as the energetic requirement of the MR1 residues that are
central to the interaction with the MAIT TCR.The 14 singlesite alanine mutants were transfected into C1R cells, and cells
were then sorted for high levels of MR1 expression by flow
cytometry using coexpressed GFP (Fig. 7).
Jurkat cells expressing human MAIT TCRs (with either
TRBV6-1, TRBV6-4, or TRBV20 pairing  chains) were
incubated for 16–20 h, with C1R cells expressing either
wild-type or each mutant MR1, in the absence or presence
of S. typhimurium. Activation of MAIT TCR–expressing
Jurkat cells was determined by flow cytometric analysis of
up-regulation of cell surface CD69 expression. Of the 14 MR1
mutants tested, mutation of 9 residues (Asp57, Arg61, Met72,
Val75, Arg79, Thr138, Gln141, Asn155, and Arg167) had no
significant impact on MAIT activation; two residues (Asn146
and His148) had a minor effect on MAIT TCR activation;
one mutation (Leu151Ala) resulted in enhanced autoreactivity in the absence of bacteria; and, most importantly, two
mutants (Leu65 and Glu158) markedly reduced MAIT TCR
activation (Fig. 7 A). The pattern of the effect of these mutants was the same, regardless of which MAIT TCR was used
MAIT TCR–MR1 recognition | Reantragoon et al.
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Figure 5. Activation of mutant SKW3.TRBV20 cell lines by different bacterial species. 11 mutant  chain (A) and 14 mutant  chain (B) SKW3.
TRBV20 cell lines were tested for activation by E. coli, S. epidermidis, K. pneumoniae, and P. aeruginosa. Shaded bars show the fold increase in CD69 surface expression (fold increase in MFI) of mutant SKW3.TRBV20 cells co-incubated with C1R cells infected with bacteria at an MOI of 100 compared with
SKW3.TRBV20 cells co-incubated with uninfected C1R cells (open bars). The experiments shown in A and B were also performed at an MOI of 1 and 10,
with similar results (not depicted). These experiments were performed three times, with similar results.
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in the activation assay. Strikingly, these two key positions
map centrally to the MR1-Ag–binding cleft, directly opposite each other (Fig. 7 B). Moreover, the “autoreactive” and
less impacted positions are proximal to Glu158 on the 2helix. The effect of these key positions (Leu65 and Glu158) indicates that there is a centrally located and extremely focused
energetic hot spot on MR1 that underpins recognition by
the MAIT TCR.
DISCUSSION
MAIT cells share many characteristics with NKT cells in that
both cell types express invariant TCR- chains paired preferentially with a restricted range of TCR- chains (Godfrey
et al., 2010b). Minor differences exist in that the NKT receptor  chain has little or no N-region variation at the V-J
junction whereas MAIT  chains can tolerate some N-region
variation at this junction (Tilloy et al., 1999; Bendelac et al.,
2007). Nonetheless, both types of T cell have appropriated
their largely innate receptors from the pool of  TCRs that
are considered part of the adaptive immune repertoire. Both
T cells are activated by MHC-I–like Ag-presenting molecules (CD1d and MR1 for NKT and MAIT cells, respectively). In contrast to NKT recognition, the underlying basis
JEM Vol. 209, No. 4

of the MAIT TCR–MR1 interaction is unclear, largely because the identity of the putative MR1-restricted ligand is
unknown (Huang et al., 2008); indeed, it has not yet been
definitively shown that MR1 presents self- or bacterially derived Ags. Nevertheless, we used a combined structural and
mutagenesis approach (a proven approach used to understand
biased TCR usage in pMHC and CD1d-Ag recognition;
Borg et al., 2005; Scott-Browne et al., 2007; Wun et al.,
2008) to provide the first insight into the specificity requirements that underscore MAIT cell activation by MR1. Initially, we determined the structure of the human MAIT
TCR (V7.2J33-V2), which showed that the CDR loops
formed an ordered Ag-binding interface, thereby suggesting
that there is limited conformational plasticity in the MAIT
TCR–MR1 interaction. Further, the MAIT TCR structure
showed that the central binding pocket, lined by the CDR3
and CDR3 loops, markedly contrasted to that of the human
NKT TCR (Kjer-Nielsen et al., 2006), differences that presumably reflect that MAIT and NKT cells are activated by
MR1 and CD1d, respectively.
Our MAIT TCR mutagenesis studies identified V residues Gly28 and Asn30 from CDR1, Tyr48 from CDR2,
and Asp92, Asn94, and Tyr95 from CDR3 (J) as being
769
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Figure 6. The  chain residues crucial to MAIT TCR recognition are conserved in two other MAIT TCRs. The mutant  chain residues observed
to diminish bacterial activation in SKW3.TRBV20 cell lines (Gly28Ala, Asn30Ala, Tyr48Ala, Asp92Ala, Asn94Ala, and Tyr95Ala, as well as control Ser27Ala
and Ser93Ala mutations) were introduced into the MAIT.TRBV6-1 and MAIT.TRBV6-4 TCRs before transduction of MAIT TCR genes into SKW3 cells. SKW3.
TRBV6-1 and SKW3.TRBV6-4 cell lines transduced with mutants Ser27Ala, Gly28Ala, Asn30Ala, Tyr48Ala, or Tyr95Ala (A), or mutants Asp92Ala, Ser93Ala,
or Asn94Ala (B) were then tested for activation by S. typhimurium, S. epidermidis, K. pneumoniae, and P. aeruginosa. Shaded bars show the fold increase
in CD69 surface expression (fold increase in MFI) of mutant SKW3.TRBV6-1 or mutant SKW3.TRBV6-4 cells co-incubated with C1R cells infected with
bacteria at an MOI of 100 compared with SKW3.TRBV6-1 or SKW3.TRBV6-4 cells co-incubated with uninfected C1R cells (open bars). These experiments
were performed three times, with similar results.
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with similar results (not depicted). (B) The effects of the MR1 mutants
were mapped onto the human MR1 homology model. Mutations that had
no impact on MAIT TCR activation is shown in gray; impact on autoreactivity is shown in orange; mutants that markedly reduced MAIT TCR activation are shown in red.
MAIT TCR–MR1 recognition | Reantragoon et al.
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Figure 7. The effect of mutation of MR1 residues on MAIT TCR
activation. (A) 13 mutant MR1, as well as wild-type MR1 (C1R.WT) and
parental C1R, cell lines were either not infected (open bars) or infected
(shaded bars) with S. typhimurium at a multiplicity of infection (MOI) of 1.
After infection, Jurkat.TRBV 20, Jurkat.TRBV 6–1, or Jurkat.TRBV 6–4 cell
lines were then added for 16 h before measurement of increase in CD69
surface expression (MFI) by staining and flow cytometric analysis. This
experiment was performed twice with similar results. Mutant Arg167Ala
MR1 C1R cells activated Jurkat.MAIT cells similarly to wild-type MR1 C1R
cells (not depicted). The experiment was also performed at an MOI of 10

important or crucial for MAIT TCR activation, regardless of
whether the MAIT TCR expressed V2 or V13. Notably,
the importance of these residues in MR1-restricted activation explains the invariant selection of the V7.2-J33  chain
segments that uniquely encode this cluster of residues. These
residues are fully conserved in homologous V-J combinations selected across humans, mice, sheep, and cattle (Tilloy
et al., 1999; Goldfinch et al., 2010; Fig. S4). This pattern of
germline V and J residues defining cognate activation
therefore has a similar basis to the invariant selection of
V24-J18 by NKT cells in their CD1d-restricted recognition
of glycolipids (Gadola et al., 2006; Kjer-Nielsen et al., 2006).
The small energetic footprint of the MAIT TCR was
mirrored by the small energetic footprint on MR1, where
mutation of only two residues, Leu65 and Glu158, markedly
reduced MAIT TCR activation, regardless of the V usage
of the MAIT TCR. In addition, one mutation, Leu151Ala,
promoted MAIT TCR–MR1 autoreactivity, and this position was previously shown to determine human and mouse
MAIT TCR–MR1 cross-species reactivity (Huang et al., 2009).
These three positions clustered closely, and were centrally
located within the Ag-binding cleft of MR1, tentatively suggesting that the MAIT TCR docks centrally on MR1; it is
also conceivable that these residues are involved in stabilization of Ag binding to MR1. A central MAIT TCR–MR1
docking mode would contrast with that of the NKT TCR–
CD1d-Ag interaction, in which the NKT TCR is perched
above the F-pocket of CD1d, whereupon the CDR2 loop
makes critical contacts with CD1d (Godfrey et al., 2010a).
In NKT cells, differential V usage is observed, with some
regions of sequence conservation observed between the different V families. These conserved V residues were important not only for NKT cognate interaction but also for the
cross-species reactivity between mouse and human CD1d
(Wun et al., 2008). Although MAIT cells also preferentially
select a few V families, there is limited sequence identity
between the CDR1 and CDR2 regions of human V2
and V13 (Tilloy et al., 1999), suggesting that the reported
cross reactivity of human MAIT cells on mouse MR1 may be
largely underpinned by the V-J chain residues interacting
with the MR1 “hotspot.” Indeed, our functional data suggests that differential V usage in MAIT cells cannot be assigned to single-residue contributions. Importantly, using a
variety of bacteria as sources of MAIT TCR stimulation, we
demonstrated that individual residues within the V chain
did not play a controlling role in MAIT cell activation when
analyzed by mutagenesis, which is perhaps consistent with
the lack of  chain sequence conservation in humans.
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MATERIALS AND METHODS
Generation of MR1-expressing APCs. Full-length cDNA genes encoding either human or murine MR1 were cloned into a modified version of
p-MSCV-IRES-eGFP (pMIG; D.Vignali, St. Jude Children’s Research Hospital, Memphis, TN; Liu et al., 1997; Pear et al., 1998). 293T packaging cells
were then transfected with retroviral vectors using FuGENE 6 (Roche), and
C1R or HeLa cells were transduced with retroviral supernatant. MR1 was
detected on the surface of transduced cells with the MR1-reactive mAb 26.5
(Huang et al., 2005). A preT-specific mAb 8A5 generated against recombinantly expressed preTCR (Pang et al., 2010) was used as an isotype control in
staining experiments.
Generation of T cell lines expressing MAIT TCRs. Full-length human
cDNA TCR  and  chain genes were cloned into a self-cleaving 2A peptidebased pMIG vector (Szymczak et al., 2004) and transduced into parental hybridoma Jurkat or SKW3 T cells using 293T packaging cells. The human
T cell line SKW3 lacks endogenous TCR expression but possesses the
CD3 and other components of the signaling apparatus. Jurkat lacks endogenous TCR but has an endogenous TCR and CD3 components. Expression of heterologous TCR genes in SKW3 and Jurkat restores parental
TCR specificity that can be assayed by up-regulation of CD69 using flow
cytometry (Fig. S5 and Fig. S6). SKW3 cells were also transduced with hybrid
JEM Vol. 209, No. 4

MAIT TCRs containing the CDR3 regions from either an abacavirspecific, TRBV20-positive T cell clone, ABC (Chessman et al., 2008); or
from an Epstein–Barr-specific, TRBV6-1–positive T cell clone (SB27; Tynan
et al., 2005b).
Activation studies with MAIT TCR–expressing T cell lines. Jurkat or
SKW3 T hybridoma cells expressing human MAIT TCRs were incubated for
16–20 h with APCs expressing human MR1 (or mutants thereof), in the
absence or presence of S. typhimurium, P. aeruginosa, K. pneumoniae, E. coli, or
S. epidermidis. Activation of MAIT TCR–expressing T cells was determined
by flow cytometric analysis of up-regulation of cell surface CD69 expression.
The 25 SKW3 cell lines expressing TRBV20 Ala substitutions were also incubated with beads coated with anti-CD3 and anti-CD28 mAbs titrated to produce activation that just achieved plateau levels of stimulation of SKW3 cells
expressing a wild-type MAIT TCR.
Generation of MAIT TCR mutants. MAIT TCR genes encoding single
alanine-mutations were generated by the QuikChange Site-Directed Mutagenesis method (Stratagene). All mutant genes were fully sequenced before
subcloning into the 2A peptide-based pMIG vector and subsequent retro
viral transfer into Jurkat and SKW3 cells. Residues to be mutated were selected on the basis of the solved crystal structure of a MAIT TCR, and
include the following CDR residues: CDR1: Ser27, Gly28, and Asn30;
CDR2: Tyr48,Val50, Leu51, and Asp52; CDR3: Asp92, Ser93, Asn94, and
Tyr95; CDR1: Phe28, Gln29, Thr31, Thr32, and Leu26 (Leu26 as a control); CDR2: Asn51, Glu52, Gly53, Ser54, and Lys55; CDR3: Arg97,
Ser99, Gly100, and Phe102.
Protein expression and purification. The MAIT TRBV20 and TRBV6-1
and TRBV6-4 TCRs were expressed, refolded, and purified using an engineered disulfide linkage in the constant domains between the TRAC and
TRBC, essentially as described previously (Clements et al., 2002). In brief, the
 and  chain of the MAIT TCR were expressed separately as inclusion bodies in BL21 E. coli strain. Inclusion bodies were resuspended in 8 M Urea,
20 mM Tris-HCl, pH 8.0, 0.5 mM Na-EDTA, and 1 mM DTT. TCRs were
refolded by flash dilution in a solution containing 5 M Urea, 100 mM Tris,
pH 8.0, 2 mM Na-EDTA, 400 mM l-arginine-HCl, 0.5 mM oxidized glutathione, 5 mM reduced glutathione, PMSF, and pepstatin A. The refolding
solution was then dialyzed to eliminate the urea. The resulting refolded protein was then purified sequentially by DEAE anion exchange, gel filtration,
and Mono-Q anion exchange chromatography.
Crystallization, structure determination, and refinement. The
MAIT TCR V7.2J33-V2 (7–10 mg/ml in 10 mM Tris, pH 8.0, and
150 mM NaCl) crystallized at 20°C in 25% PEG 1500, 0.1 M MIB buffer
(sodium malonate/Imidazole/boric acid in molar rations of 2:3:3), pH 5.0,
via the hanging drop vapor diffusion technique. Equal ratio of the protein
to mother liquor resulted in plate-like crystals after 1–3 d. The crystals
were flash frozen before data collection in mother liquor containing 20%
glycerol. The crystals diffracted to 1.7 Å at the MX2 beamline at the Australian Synchrotron facility in Melbourne, Australia (Table 1). The crystals
belong to the space group P212121, with one molecule in the asymmetric
unit. The crystal structure of the MAIT TCR was solved by molecular replacement method with the program Phaser from the CCP4 Suite (Collaborative Computational Project, Number 4, 1994), using ELS4 TCR
(Protein Data Bank ID accession code 2NX5; Tynan et al., 2007) without
the CDR loops and loops connecting the variable and constant domains as
a model. ARP/wARP in the CCP4 suite (Collaborative Computational
Project, Number 4, 1994) was used for automated model building, and
Refmac was used for restrained refinement (Table 1). The quality of structure was confirmed at the Research Collaboratory for Structural Bioinformatics Protein Data Bank Data Validation and Deposition Services website
(http://www.rcsb.org/pdb/home/home.do; Protein Data Bank accesion
code 4DZB). All molecular graphics representations were created using
PyMOL (DeLano, 2002).
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However, replacement of whole MAIT CDR3 loops with
those from non–MAIT TCRs abolishes T cell activation indicating a more complex role for CDR3 residues in MAIT
specificity. It is possible that the conformation of the CDR3
loop can impact on the conformation of the CDR3 loop,
thereby impacting MR1 recognition in a manner similar to
how V-based changes impact the NKT TCR  chain conformation and resultant CD1d-Ag recognition (Kjer-Nielsen
et al., 2006; Pellicci et al., 2009), or in a manner analogous to
that recently observed in MHC-restricted immunity (Stadinski
et al., 2011). It is also possible that the selective V usage by
MAIT cells is shaped by a putative positive selecting endogenous ligand, as suggested for NKT cells (Wei et al., 2006),
and/or avoidance of self-MR1 reactivity with endogenous
MR1-bound ligands.
In MHC-restricted immunity, the TCR can ligate the
pMHC landscape through a range of docking modes to mediate viral immunity, alloreactivity, and autoimmunity (Burrows
et al., 2010). This variability is attributable to the highly polymorphic nature of the MHC molecules, the variable peptide
cargo, and the diversity of TCR V and V usage. Moreover, MHC-restricted TCRs are inherently cross-reactive
(Archbold et al., 2008), and this cross-reactivity is often manifested in conformational plasticity of the CDR loops (or the
pMHC itself; Tynan et al., 2007; Archbold et al., 2009) upon
TCR-pMHC ligation. In contrast, our data suggest that the
MAIT TCR might be relatively rigid, which is characteristic
of innate receptors styled to recognize monomorphic or only
modestly variable Ags. Moreover, the crucial role for the same
TCR V-J residues in recognizing different species of Gramnegative and -positive bacteria suggests a highly conserved
MR1 docking mode that underpins MAIT cell activation by
diverse microbes. Collectively, our studies have provided the
first fundamental insight into the MAIT TCR–MR1 inter
action and the basis for invariant TCR chain selection.

Generation of MR1 mutants. 14 MR1 genes encoding single alanine
mutations were generated by the QuikChange Site directed mutagenesis
method (Stratagene). All mutant genes were fully sequenced before subcloning into the pMIG vector and subsequent retroviral transfer into C1R cells.
Residues to be mutated were selected on the basis of the human MR1 homology model, and include the following residues: Asp57, Arg61, Leu65,
Met72, Val75, Arg79, Thr138, Gln141, Asn146, His148, Leu151, Asn155,
Glu158, and Arg167. Expression of MR1 was confirmed by staining with
the MR1-reactive mAb 26.5; as well as coexpression of GFP. High-expressing
MR1-transduced C1R cells were sorted by flow cytometry using the coexpressed GFP gene, and sorted cells were subsequently used in activation assays with Jurkat cells expressing MAIT TCRs.
Online supplemental material. Fig. S1 shows a comparison of the
CDR3 amino acid sequences of MAIT TCRs using the  chains TRBV6-1,
TRBV6-4, and TRBV20. Fig. S2 shows a comparison of the CDR1 and
CDR2 regions of V chains of human and mouse MAIT TCRs. Fig. S3
shows a comparison of the CDR3 amino acid sequences of four TCR
 chains. Fig. S4 shows the alignment of MAIT V7.2/J33 amino acid
sequences from four species. Fig. S5 shows the gating strategy for CD69
measurement. Fig. S6 shows the CD69 measurement of gated SKW3 cells.
Online supplemental material is available at http://www.jem.org/cgi/
content/full/jem.20112095/DC1.
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